Skip to main content
NVDA+0.57%AAPL+0.41%GOOGL+0.93%MSFT+0.39%AMZN+0.36%TSM-0.16%SPCX+1.09%META+0.17%AVGO-1.10%TSLA+0.05%SKHY-1.36%MU+0.23%LLY-2.33%BRK-B-0.88%AMD+0.69%JPM-1.24%WMT-2.70%ASMLa-0.27%XOM+0.87%V-1.79%JNJ-1.06%INTC+3.71%0700.HK-0.23%MA-2.15%1398.HK+0.78%ABBV-0.65%CSCO+0.65%LRCX+1.44%CVX-0.08%AMAT-0.12%COST-1.54%AP2d+1.46%ORCL-0.35%BAC-0.96%CAT-1.92%KO-0.88%DELL-0.30%0005.HK-0.63%PG-2.05%HSBA.L-0.64%UNH-2.10%3988.HK+1.16%GE-1.76%1816.HK+0.48%ARM-1.37%0857.HK-0.51%0939.HK+1.34%1288.HK+0.61%PM-1.59%MS-2.43%GBPAUD+1.23%AUDUSD-1.17%GBPCHF+1.02%USDCHF+0.94%GBPNZD+0.79%GBPCAD+0.79%NZDUSD-0.75%USDCAD+0.73%AUDJPY-0.69%EURGBP-0.65%USDTHB+0.64%EURAUD+0.60%EURUSD-0.60%GBPJPY+0.57%USDJPY+0.51%AUDCAD-0.47%AUDNZD-0.43%GBPTRY+0.41%CHFJPY-0.40%PLNJPY+0.39%EURCHF+0.34%GBPHKD+0.32%SGDJPY+0.32%USDTRY+0.29%NOKJPY+0.29%GBPMXN-0.28%AUDCHF-0.26%NZDJPY-0.22%CADCHF+0.22%CADJPY-0.21%NZDCHF+0.20%USDZAR+0.20%USDSEK+0.17%EURNZD+0.16%USDILS+0.16%USDMXN+0.14%USDCNH-0.14%USDNOK+0.13%EURCAD+0.13%EURZAR+0.13%GBPZAR+0.11%NZDSGD-0.11%EURSEK+0.11%CHFSEK+0.10%USDSGD+0.10%AUDNOK+0.10%EURJPY-0.09%NZDMXN-0.09%EURNOK+0.09%CHFNOK+0.08%EURHKD-0.07%GBPUSD+0.06%AUDSGD+0.06%USDDKK+0.05%EURSGD+0.04%USDCOP-0.04%USDPLN+0.04%CHFSGD+0.04%USDHKD+0.03%GBPSGD+0.02%EURPLN-0.02%NZDCAD-0.01%AUDDKK+0.01%EURCNH0.00%EURDKK0.00%EURCZK0.00%XAGUSD+0.70%GAGUSD+0.70%HG1-0.64%USOIL-0.49%UKOIL-0.33%S1-0.27%XPTUSD-0.25%COTTON-0.21%XNGUSD-0.08%GAUUSD-0.06%XAUUSD-0.06%C1+0.03%BTCUSD-0.19%ETHUSD+7.44%USDTUSD-0.03%XRPUSD+0.63%SOLUSD-0.64%TRXUSDT+1.07%ZECUSDT-0.02%DOGEUSD-0.17%LINKUSD-2.08%XMRUSDT+0.57%XLMUSD+2.18%BCHUSDT-0.61%UNIUSD-0.74%LTCUSD+0.07%SUIUSD+1.70%HBARUSDT+1.75%TONUSD+15.77%TAOUSDT+0.27%AAVEUSD-2.45%DOTUSDT+2.87%ICPUSDT-1.58%ONDOUSDT+0.21%WLDUSDT+10.30%ARBUSDT-0.33%JUPUSDT-1.11%ATOMUSDT+1.34%INJUSDT-3.04%STXUSDT+18.01%FETUSDT+3.26%SEIUSDT+0.33%PYTHUSDT-3.04%TIAUSDT-0.07%IMXUSDT+0.97%GRTUSDT-0.44%OPUSDT-0.24%WIFUSDT+3.87%IOTAUSDT+4.03%POLUSDT-4.75%AXSUSDT+0.76%FARTCOINUSDT-0.30%EOSUSDT+4.07%DYDXUSDT+3.32%GALAUSDT+3.85%ORDIUSDT+1.22%NOTUSDT+1.55%RONINUSDT+0.06%NVDA+0.57%AAPL+0.41%GOOGL+0.93%MSFT+0.39%AMZN+0.36%TSM-0.16%SPCX+1.09%META+0.17%AVGO-1.10%TSLA+0.05%SKHY-1.36%MU+0.23%LLY-2.33%BRK-B-0.88%AMD+0.69%JPM-1.24%WMT-2.70%ASMLa-0.27%XOM+0.87%V-1.79%JNJ-1.06%INTC+3.71%0700.HK-0.23%MA-2.15%1398.HK+0.78%ABBV-0.65%CSCO+0.65%LRCX+1.44%CVX-0.08%AMAT-0.12%COST-1.54%AP2d+1.46%ORCL-0.35%BAC-0.96%CAT-1.92%KO-0.88%DELL-0.30%0005.HK-0.63%PG-2.05%HSBA.L-0.64%UNH-2.10%3988.HK+1.16%GE-1.76%1816.HK+0.48%ARM-1.37%0857.HK-0.51%0939.HK+1.34%1288.HK+0.61%PM-1.59%MS-2.43%GBPAUD+1.23%AUDUSD-1.17%GBPCHF+1.02%USDCHF+0.94%GBPNZD+0.79%GBPCAD+0.79%NZDUSD-0.75%USDCAD+0.73%AUDJPY-0.69%EURGBP-0.65%USDTHB+0.64%EURAUD+0.60%EURUSD-0.60%GBPJPY+0.57%USDJPY+0.51%AUDCAD-0.47%AUDNZD-0.43%GBPTRY+0.41%CHFJPY-0.40%PLNJPY+0.39%EURCHF+0.34%GBPHKD+0.32%SGDJPY+0.32%USDTRY+0.29%NOKJPY+0.29%GBPMXN-0.28%AUDCHF-0.26%NZDJPY-0.22%CADCHF+0.22%CADJPY-0.21%NZDCHF+0.20%USDZAR+0.20%USDSEK+0.17%EURNZD+0.16%USDILS+0.16%USDMXN+0.14%USDCNH-0.14%USDNOK+0.13%EURCAD+0.13%EURZAR+0.13%GBPZAR+0.11%NZDSGD-0.11%EURSEK+0.11%CHFSEK+0.10%USDSGD+0.10%AUDNOK+0.10%EURJPY-0.09%NZDMXN-0.09%EURNOK+0.09%CHFNOK+0.08%EURHKD-0.07%GBPUSD+0.06%AUDSGD+0.06%USDDKK+0.05%EURSGD+0.04%USDCOP-0.04%USDPLN+0.04%CHFSGD+0.04%USDHKD+0.03%GBPSGD+0.02%EURPLN-0.02%NZDCAD-0.01%AUDDKK+0.01%EURCNH0.00%EURDKK0.00%EURCZK0.00%XAGUSD+0.70%GAGUSD+0.70%HG1-0.64%USOIL-0.49%UKOIL-0.33%S1-0.27%XPTUSD-0.25%COTTON-0.21%XNGUSD-0.08%GAUUSD-0.06%XAUUSD-0.06%C1+0.03%BTCUSD-0.19%ETHUSD+7.44%USDTUSD-0.03%XRPUSD+0.63%SOLUSD-0.64%TRXUSDT+1.07%ZECUSDT-0.02%DOGEUSD-0.17%LINKUSD-2.08%XMRUSDT+0.57%XLMUSD+2.18%BCHUSDT-0.61%UNIUSD-0.74%LTCUSD+0.07%SUIUSD+1.70%HBARUSDT+1.75%TONUSD+15.77%TAOUSDT+0.27%AAVEUSD-2.45%DOTUSDT+2.87%ICPUSDT-1.58%ONDOUSDT+0.21%WLDUSDT+10.30%ARBUSDT-0.33%JUPUSDT-1.11%ATOMUSDT+1.34%INJUSDT-3.04%STXUSDT+18.01%FETUSDT+3.26%SEIUSDT+0.33%PYTHUSDT-3.04%TIAUSDT-0.07%IMXUSDT+0.97%GRTUSDT-0.44%OPUSDT-0.24%WIFUSDT+3.87%IOTAUSDT+4.03%POLUSDT-4.75%AXSUSDT+0.76%FARTCOINUSDT-0.30%EOSUSDT+4.07%DYDXUSDT+3.32%GALAUSDT+3.85%ORDIUSDT+1.22%NOTUSDT+1.55%RONINUSDT+0.06%
TT

TG Therapeutics, Inc. (TGTX)

NASDAQ • Healthcare

$55.78
-$0.4 (-0.7%)
Market closed

Last close at September 30, 2026 at 20:00 UTC

Open$56.41
Day Range$55.36 - $56.98
Avg. Volume (3M)1.7M
Market Cap$8.5B
P/E Ratio18.3
52 Week Range
$26.76$59.3
Next EarningsIn 32 daysNov 2, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$240.3M100%
Gross Profitminus cost of goods$199.1M83%
Operating Incomeminus R&D and overhead$21.6M9%
Net Incomeminus taxes and the rest$7.7M3%

In plain terms: out of every $100 in revenue, TG Therapeutics, Inc. keeps $3 as net profit.

Fundamentals & Financials

Revenue (TTM)
$799.5M
Net Income (TTM)
$441.4M
EPS (TTM)
$3.04
ROA (TTM)
26.93%
Current Ratio
4.27
Dividend Yield
0%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-60.0%Q1 2026$0.14
-39.1%Q2 2026$0.14
-83.6%Q3 2026$0.05
Next

Nov 2

in 32 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Miss -83.6%

TG Therapeutics’ results for the second fiscal quarter of 2026 were mixed versus consensus, with revenue topping expectations while EPS trailed; the company reported the quarter on August 3, 2026. Revenue rose 70.3% to about $240.3 million (up from roughly $141.1 million a year ago) and topped consensus, coming in at $240.3 million versus a $229.8 million estimate (+4.6%). EPS of $0.05 trailed the $0.31 estimate (-84%) and was down from $0.17 a year ago, alongside net income that fell 72.4% year over year to about $7.8 million (from roughly $28.2 million). Profitability remained positive, with gross profit of about $199.1 million translating to a gross margin of roughly 83%, while operating income of around $21.7 million produced an operating margin near 9%. The company generated operating cash flow of about $21.4 million and repurchased roughly $100.0 million of stock during the quarter. For the next period, consensus calls for EPS of $0.36 on revenue of $247.1 million.

View full earnings history

About TG Therapeutics, Inc.

TG Therapeutics, Inc. is a commercial-stage biotechnology company listed on the NASDAQ as TGTX that develops and sells therapies for B-cell related cancers and autoimmune disorders. FY2025 revenue was $616.3 million. Its business centers on monoclonal antibodies, targeted oral inhibitors, and earlier licensed programs in immunology and oncology.

Name
TG Therapeutics, Inc.
CEO
Michael S. Weiss
Website
www.tgtherapeutics.com
Industry
Healthcare
Year Founded
1993
Employees
399

Today's Snapshot

AI-generated

The day ended with TGTX 0.7% lower at 55.78, in line with a weaker sector.

Trading Volume

Below 10d avg (2.0M)

1.8M

vs S&P 500 Today

Underperforming Market

-0.92%

Updated: September 30, 2026 at 20:15 UTC

Technical Indicators

3 Buy3 Neutral2 Sell
TGTX presents a cautiously bullish technical picture with the price at 55.78 sitting above the 50-, 100- and 200-day averages while short-term averages lie slightly above current levels, indicating a minor pullback rather than trend reversal. Momentum readings are mostly neutral and MACD lacks strong directional conviction, while ADX around 24 points signals moderate trend strength and ATR points to steady volatility. Positive on-balance volume supports the longer-term bias and the classic pivot at 55.89 is essentially near market. Technical takeaway: Buy—longer-term moving averages and supportive volume outweigh muted short-term momentum.
All signals
  • EMA (5 indicators)$43.20 - $56.32
    Buy
  • RSI (14)51.58
    Neutral
  • Stochastic %K (14, 3, 3)55.35
    Neutral
  • MACD Level (12, 26)0.78
    Neutral

Peers & Related Assets

KRYSKrystal Biotech, Inc.
$332.56-0.8%
ARWRArrowhead Pharmaceuticals, Inc.
$65.45-1.2%
KYMRKymera Therapeutics, Inc.
$111.79+1.2%
PTGXProtagonist Therapeutics, Inc.
$140.89-0.1%
PCVXVaxcyte, Inc.
$56.9+0.4%
IMVTImmunovant, Inc.
$33.78+1.0%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.